The potential applications of artificial intelligence in biomarker discovery for cardiovascular diseases
Year: 2025
Type: article
Abstract: Cardiovascular diseases (CVDs) are the leading global cause of early mortality and disability, characterized by their complex, multifactorial nature, which demands personalized diagnostic and therapeutic strategies. Current diagnostic methods for CVDs, while essential, have limitations in sensitivity, specificity, and real-time monitoring, which can impede early and accurate disease detection. Biomarkers emerge as pivotal tools for the enhanced diagnosis and management of CVDs, yet the challenges in their discovery and validation persist. Integrating artificial intelligence with omics technologies promises to revolutionize this field by significantly improving the precision and speed of biomarker discovery. This innovative approach, merging the analysis of genetic variants with expression patterns linked to specific phenotypes, holds the potential to uncover novel biomarkers and facilitate the stratification of patient groups based on individual risk factors, thereby advancing personalized medicine in cardiovascular care.
Source: Brain & Heart
DOI: 10.36922/bh.8442
Authors: Kyriacos Felekkis, Christos Papaneophytou
Language: English
Subfield: Health Information Management
Field: Health Professions
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4408460522